Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)–paclitaxel or docetaxel adjuvant chemotherapy in breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/16/2/247/328017/mdi058.pdf
Reference15 articles.
1. Optimizing chemotherapy dose density and dose intensity: new strategies to improve outcomes in adjuvant therapy for breast cancer;Gianni;Eur J Cancer,2000
2. Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer;Henderson;J Clin Oncol,2003
3. Evolving concepts in the systemic drug therapy of breast cancer;Norton;Semin Oncol,1997
4. Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
5. Mathematics and oncology: a match for life?;Piccart;J Clin Oncol,2003
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PREVALENCE AND PREDICTIVE FACTORS OF NEUTROPENIA AMONG PATIENTS WITH BREAST CANCER RECEIVING DOXORUBICINCYCLOPHOSPHAMIDE CHEMOTHERAPY AT A CANCER CENTER, SURIN HOSPITAL: A RETROSPECTIVE CASE-CONTROL STUDY;Journal of Southeast Asian Medical Research;2024-04-18
2. Exploring Predictive Risk Factors of Infusion Reactions with First Pertuzumab Administration in HER2-positive Breast Cancer Patients: A Single Institution Experience;JMA Journal;2023
3. Quality of Breast Cancer Treatment at a Rural Cancer Center in Rwanda;Journal of Global Oncology;2018-12
4. Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel-Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis of 36 Randomized Controlled Trials;Evidence-Based Complementary and Alternative Medicine;2018-06-11
5. Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella;International Journal of Nanomedicine;2017-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3